Who bought nlsl stock?
Apr 11, 2022 · Real-time trade and investing ideas on Nautilus Inc. NLS from the largest community of traders and investors.
Is NLS pharmaceutics (NLS) stock a buy or sell?
Nautilus (NLS) New York Stock Exchange NLS $4.03 -$0.06 -1.5% Price as of March 25, 2022, 4:00 p.m. ET View Interactive NLS Charts The Company is a designer, developer, manufacturer …
Who sells Nautilus (NLS) stock?
Mar 27, 2022 · Stock Exchange NYSE Industry Sporting & athletic goods, not elsewhere classified Sub-Industry N/A Sector Retail/Wholesale Current Symbol NYSE:NLS Previous Symbol CUSIP N/A CIK 1078207 Web www.nautilusinc.com Phone (360) 859-2900 Fax 360-694-7755 Employees 410 Year Founded N/A Sales & Book Value Annual Sales $552.56 million Price / Sales 0.21
What are analysts'1-year price targets for NLS pharmaceutics'stock?
Get the latest Nautilus, Inc. (NLS) stock news and headlines to help you in your trading and investing decisions.
Is NLS stock a good buy?
Nautilus has received a consensus rating of Buy.
Is NLS a buy or sell?
For example, a stock trading at $35 with earnings of $3 would have an earnings yield of 0.0857 or 8.57%. A yield of 8.57% also means 8.57 cents of earnings for $1 of investment....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.93%2Buy18.44%3Hold9.99%4Sell5.61%2 more rows
Will NLS stock go up?
Stock Price Forecast The 4 analysts offering 12-month price forecasts for Nautilus Inc have a median target of 11.50, with a high estimate of 15.00 and a low estimate of 7.00. The median estimate represents a +194.87% increase from the last price of 3.90.
Why is NLS stock dropping?
The company released fiscal first-quarter earnings on Monday that beat revenue and earnings estimates, but it wasn't enough to please investors. After the stock soared in 2020, the stock is down 30% year to date, as investors brace for a slowdown following the pandemic.Aug 10, 2021
Is Bowflex on the stock market?
Bowflex of America changed its name to Bowflex, Inc, and became a public company on the Toronto Stock Exchange. In 1999 the company changed its name to Direct Focus, Inc. and initiated an IPO on Nasdaq.
What is the target price for Baba stock?
Stock Price TargetsHigh$1,755.14Median$1,037.90Low$476.94Average$1,032.76Current Price$95.49
Is Nautilus a buy right now?
4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nautilus in the last year. There are currently 1 hold ra...
How has Nautilus' stock price been impacted by COVID-19 (Coronavirus)?
Nautilus' stock was trading at $1.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organiza...
Are investors shorting Nautilus?
Nautilus saw a decline in short interest in January. As of January 31st, there was short interest totaling 2,810,000 shares, a decline of 15.9% fro...
When is Nautilus' next earnings date?
Nautilus is scheduled to release its next quarterly earnings announcement on Monday, May 9th 2022. View our earnings forecast for Nautilus .
How were Nautilus' earnings last quarter?
Nautilus, Inc. (NYSE:NLS) released its quarterly earnings data on Tuesday, November, 9th. The specialty retailer reported $0.03 earnings per share...
What price target have analysts set for NLS?
4 Wall Street analysts have issued 1-year price objectives for Nautilus' shares. Their forecasts range from $9.00 to $16.00. On average, they expec...
Who are Nautilus' key executives?
Nautilus' management team includes the following people: James Barr , Chief Executive Officer & Director Aina E. Konold , Chief Financial Office...
What is James Barr's approval rating as Nautilus' CEO?
10 employees have rated Nautilus CEO James Barr on Glassdoor.com . James Barr has an approval rating of 99% among Nautilus' employees. This puts J...
Who are some of Nautilus' key competitors?
Some companies that are related to Nautilus include American Outdoor Brands (AOUT) , Escalade (ESCA) , Alliance Sports Group (BOLL) , American...
Is Nautilus a buy right now?
What stocks does MarketBeat like better than Nautilus?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nautilus in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Nautilus stock.#N#View analyst ratings for Nautilus or view top-rated stocks.
When is Nautilus' next earnings date?
Wall Street analysts have given Nautilus a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Nautilus wasn't one of them.
How were Nautilus' earnings last quarter?
Nautilus is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.#N#View our earnings forecast for Nautilus.
How has Nautilus' stock price been impacted by COVID-19?
Nautilus, Inc. (NYSE:NLS) announced its earnings results on Monday, August, 9th. The specialty retailer reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.13. Nautilus had a net margin of 14.56% and a trailing twelve-month return on equity of 63.65%.#N#View Nautilus' earnings history.
What guidance has Nautilus issued on next quarter's earnings?
Nautilus' stock was trading at $1.64 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NLS shares have increased by 554.3% and is now trading at $10.73.#N#View which stocks have been most impacted by COVID-19.
What price target have analysts set for NLS?
Nautilus issued an update on its second quarter 2022 earnings guidance on Monday, September, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $145 million-$155 million, compared to the consensus revenue estimate of $153.05 million.
15 Most Valuable Health and Fitness Companies in the World
5 brokers have issued 12 month price objectives for Nautilus' stock. Their forecasts range from $12.50 to $27.00. On average, they expect Nautilus' share price to reach $22.10 in the next year.
Why Nautilus Stock Was Down on Tuesday
In this article, we will take a look at the 15 most valuable health and fitness companies in the world. You can skip our detailed analysis of the health and fitness industry’s outlook for 2021, and go directly to the 5 Most Valuable Health and Fitness Companies in the World. The global health and fitness […]
Nautilus, Inc. (NLS) Fell Out Of Favor With Hedge Funds?
Excluding results from Octane Fitness, which Nautilus sold last year, revenue grew 74%. Looking further ahead, management is targeting revenue of $1 billion -- compared with $664 million on a trailing 12-month basis -- and 2 million digital members by the end of fiscal 2026.
2 Incredibly Cheap Consumer Goods Stocks
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious towards the current bull run since March, 2020 and hedging or reducing many of their long positions. Some fund managers are betting on Dow […]
10 Best Weight Loss Stocks to Buy Now
Irresistible deals are getting hard to find in mid-2021's overheated stock market, thanks in part to a post-lockdown euphoria and a whiff of potential inflation. This group of stocks includes Nautilus (NYSE: NLS) and Tattooed Chef (NASDAQ: TTCF).
Here's 1 Fitness Stock Value Investors Should Check Out
In this article, we will be looking at the 10 best weight loss stocks to buy now. To skip our detailed analysis on weight loss stocks and the fitness industry, you can go directly to the 5 Best Weight Loss Stocks to Buy Now. With the outbreak of the pandemic, the first major change the […]
Could The Nautilus, Inc. (NYSE:NLS) Ownership Structure Tell Us Something Useful?
In this clip, recorded on June 4, chief growth officer Anand Chokkavelu explains why he ranked Nautilus (NYSE: NLS) No. 1. Anand Chokkavelu: The brands Nautilus owns, you know the Nautilus brand probably, it also owns Bowflex and Schwinn.
Signals & Forecast
Every investor in Nautilus, Inc. ( NYSE:NLS ) should be aware of the most powerful shareholder groups. Institutions...
Support, Risk & Stop-loss
There are mixed signals in the stock today. The Nautilus Group Inc (The) stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is Nautilus Group Inc (The) stock A Buy?
Nautilus Group Inc (The) finds support from accumulated volume at $10.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is NLS Pharmaceutics a buy right now?
Nautilus Group Inc (The) holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
What stocks does MarketBeat like better than NLS Pharmaceutics?
3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NLS Pharmaceutics in the last year. There are currently 3 buy ratings for the stock.
What price target have analysts set for NLSP?
Wall Street analysts have given NLS Pharmaceutics a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but NLS Pharmaceutics wasn't one of them.
Who are some of NLS Pharmaceutics' key competitors?
3 brokerages have issued 12-month target prices for NLS Pharmaceutics' stock. Their forecasts range from $8.00 to $12.00. On average, they anticipate NLS Pharmaceutics' stock price to reach $10.67 in the next twelve months.
What is NLS Pharmaceutics' stock symbol?
Some companies that are related to NLS Pharmaceutics include Oncolytics Biotech (ONCY), Exicure (XCUR), Vascular Biogenics (VBLT), GlycoMimetics (GLYC), ASLAN Pharmaceuticals (ASLN), Corvus Pharmaceuticals (CRVS), Ainos (AIMD), Galecto (GLTO), Eledon Pharmaceuticals (ELDN), Capricor Therapeutics (CAPR), Palatin Technologies (PTN), Concert Pharmaceuticals (CNCE), Biophytis (BPTS), Yumanity Therapeutics (YMTX) and Cocrystal Pharma (COCP).#N#View all of NLSP's competitors..
When did NLS Pharmaceutics' lock-up period expire?
NLS Pharmaceutics trades on the NASDAQ under the ticker symbol "NLSP."
Who are NLS Pharmaceutics' major shareholders?
NLS Pharmaceutics' lock-up period expired on Wednesday, July 28th. NLS Pharmaceutics had issued 4,819,277 shares in its initial public offering on January 29th. The total size of the offering was $20,000,000 based on an initial share price of $4.15.
Overview
NLS Pharmaceutics' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (0.36%) and Citadel Advisors LLC (0.09%).
Enhance Your Feed: NLS Plus
NLS provides real-time intraday last sale data for all securities traded in Nasdaq systems and the FINRA Trade Reporting Facility (TRF) operated in partnership with FINRA/Nasdaq TRF. Nasdaq has more liquidity than any other U.S. exchange, making NLS a reliable and accurate source for real-time, intraday trade data.
Agreements & Forms
NLS Plus is a comprehensive but affordable data feed providing access to all Nasdaq U.S. markets' last sale data as well as consolidated volume. NLS Plus includes all trade data from the following Nasdaq markets for U.S. exchange-listed securities:
Shares of the home gym-equipment maker got crushed even though it beat earnings estimates. Here's what you need to know
To initiate this data on a data feed, firms must submit the appropriate documentation and receive prior approval from Nasdaq:
What happened
Reuben Gregg Brewer believes dividends are a window into a company's soul. He tries to invest in good souls.
So what
Shares of home gym-equipment company Nautilus ( NYSE:NLS) fell as much as 27.5% on Feb. 23 before regaining some lost ground. Still, by roughly 2 p.m. EST, the stock remained lower by a huge 20%. The company's earnings, released after the market closed on Feb. 22, were the reason, but that needs some explanation.
Now what
The bottom line for Nautilus was pretty good. The fitness-equipment maker earned $0.89 per share in the fourth quarter of 2020 compared to just $0.12 in the same quarter of 2019. That's an impressive increase, helped along by the fact that the coronavirus pandemic forced people to avoid public spaces, like gyms.
